Daniela Stanga

Research And Development Branch
Montreal, QC, Canada

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications

Erratum: A Spike-Accum bioconjugate protein vaccine confers potent SARS-CoV-2-specific immunity.

Erratum: A Spike-Accum bioconjugate protein vaccine confers potent SARS-CoV-2-specific immunity.

Journal: iScience
Published: October 31, 2025

ARM-X: an adaptable mesenchymal stromal cell-based vaccination platform suitable for solid tumors.

ARM-X: an adaptable mesenchymal stromal cell-based vaccination platform suitable for solid tumors.

Journal: Stem cell research & therapy
Published: January 24, 2025

A Spike-Accum bioconjugate protein vaccine confers potent SARS-CoV-2-specific immunity.

A Spike-Accum bioconjugate protein vaccine confers potent SARS-CoV-2-specific immunity.

Journal: iScience
Published: November 14, 2024

Local delivery of accutox® synergises with immune-checkpoint inhibitors at disrupting tumor growth.

Local delivery of accutox® synergises with immune-checkpoint inhibitors at disrupting tumor growth.

Journal: Journal of translational medicine
Published: February 11, 2024

A1-reprogrammed mesenchymal stromal cells prime potent antitumoral responses.

A1-reprogrammed mesenchymal stromal cells prime potent antitumoral responses.

Journal: iScience
Published: October 10, 2023

NOX2 deficiency enhances priming and activation of the NLRP3 inflammasome.

NOX2 deficiency enhances priming and activation of the NLRP3 inflammasome.

Journal: The Journal of allergy and clinical immunology
Published: June 22, 2023

An engineered Accum-E7 protein-based vaccine with dual anti-cervical cancer activity.

An engineered Accum-E7 protein-based vaccine with dual anti-cervical cancer activity.

Journal: Cancer science
Published: May 12, 2023

Intratumoral administration of unconjugated Accum™ impairs the growth of pre-established solid lymphoma tumors.

Intratumoral administration of unconjugated Accum™ impairs the growth of pre-established solid lymphoma tumors.

Journal: Cancer science
Published: March 31, 2023

Publisher Correction: Characterization of three TRAPPC11 variants suggests a critical role for the extreme carboxy terminus of the protein.

Publisher Correction: Characterization of three TRAPPC11 variants suggests a critical role for the extreme carboxy terminus of the protein.

Journal: Scientific reports
Published: November 11, 2020

TRAPPing a neurological disorder: from yeast to humans.

TRAPPing a neurological disorder: from yeast to humans.

Journal: Autophagy
Published: March 03, 2020

Deficiencies in vesicular transport mediated by TRAPPC4 are associated with severe syndromic intellectual disability.

Deficiencies in vesicular transport mediated by TRAPPC4 are associated with severe syndromic intellectual disability.

Journal: Brain : a journal of neurology
Published: July 17, 2019

Characterization of three TRAPPC11 variants suggests a critical role for the extreme carboxy terminus of the protein.

Characterization of three TRAPPC11 variants suggests a critical role for the extreme carboxy terminus of the protein.

Journal: Scientific reports
Published: April 10, 2019
Showing 1-12 of 17

Last Updated: 09/26/2026